文献速递肺外科心外重症与机械循环支持

肺移植术后患者报告结局的改善不受体外膜氧合作为移植桥接的影响

Improvement in patient-reported outcomes after lung transplantation is not impacted by the use of extracorporeal membrane oxygenation as a bridge to transplantation.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-02-22

单中心前瞻性队列研究纳入189例肺移植受者,其中17例以ECMO桥接移植。术后3、6、12个月用SF12-PCS、SF12-MCS、AQ20R、EQ5D和GDS评估健康相关生活质量与抑郁症状。各组的SF12-PCS、AQ20R、EQ5D和GDS改善均超过最小临床重要差异,SF12-MCS无变化,组间改善总体相似。

要点

  • 以ECMO桥接肺移植者术后健康相关生活质量和抑郁症状的改善与非桥接者相似。
  • 所有组SF12-PCS、AQ20R、EQ5D和GDS的改善均超过最小临床重要差异。
  • SF12-MCS在移植后未见变化,EQ5D显示门诊患者获益趋势较小。

核心结论

  • 需要ECMO桥接肺移植的重症患者似乎可获得与非桥接者相似的健康相关生活质量和抑郁症状改善。

研究设计与样本

  • 单中心前瞻性队列研究,纳入189例受者,其中17例以ECMO桥接移植。
  • 移植前及术后3、6、12个月用SF12-PCS、SF12-MCS、AQ20R、EQ5D和GDS评估,采用分段线性混合效应模型校正年龄、性别、诊断、术前FEV1、6分钟步行距离和肺分配评分。

主要发现

  • 所有组SF12-PCS、AQ20R、EQ5D和GDS的改善均超过最小临床重要差异。
  • SF12-MCS定义的HRQL在移植后未见变化。
  • 组间改善总体相似,仅EQ5D显示门诊患者获益趋势较小,可能与其移植前HRQL较好有关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Extracorporeal membrane oxygenation (ECMO) is increasingly used as a bridge to lung transplantation. The impact of preoperative ECMO on health-related quality of life (HRQL) and depressive symptoms after lung transplantation remains unknown, however. METHODS: In a single-center prospective cohort study, we assessed HRQL and depressive symptoms before and at 3, 6, and 12 months after lung transplantation using the Short Form 12 Physical and Mental Component Scores (SF12-PCS and SF12-MCS), Airway Questionnaire 20-Revised (AQ20R), EuroQol 5D (EQ5D), and Geriatric Depression Scale (GDS). Changes in HRQL were quantified by segmented linear mixed-effects models controlling for age, sex, diagnosis, preoperative forced expiratory volume in 1 second, 6-minute walk distance, and Lung Allocation Score. We compared changes in HRQL among subjects bridged with ECMO, subjects hospitalized but not on ECMO, and subjects called in for transplantation as outpatients. RESULTS: Out of 189 subjects, 17 were bridged to transplantation with ECMO. In all groups, improvements in HRQL following lung transplantation exceeded the minimally clinically important difference using the SF12-PCS, AQ20R, EQ5D, and GDS. HRQL defined by SF12-MCS did not change after transplantation. Improvements were generally similar among the groups, except for EQ5D, which showed a trend toward less benefit in the outpatients, possibly due to their better HRQL before lung transplantation. CONCLUSIONS: Subjects ill enough to require ECMO as a bridge to lung transplantation appear to achieve similar improvements in HRQL and depressive symptoms as those who do not. It is reassuring to both providers and patients that lung transplantation provides substantial improvements in HRQL, even for those patients who are critically ill in the run up to transplantation.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kolaitis NA, Soong A, Shrestha P, et al. Improvement in patient-reported outcomes after lung transplantation is not impacted by the use of extracorporeal membrane oxygenation as a bridge to transplantation. J Thorac Cardiovasc Surg. 2018. PMID: 29550072. doi:10.1016/j.jtcvs.2018.01.101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。